( )
PR
Aldevron to generate antibodies for erythropoietin research consortium
12/15/11 12:00
Aldevron announces participation in a three year, €3.9 million research project to study the long-term risks of erythropoietin use. Read More...
Genovac is now Aldevron Freiburg
07/01/11 16:05
As of July 1, 2011 GENOVAC has officially changed it's name to Aldevron Freiburg. The core team and technologies will remain intact. Read More...
Nature Technology Corporation and Aldevron to Manufacture First Genetic Cosmetic
05/11/11 10:46
Nature Technology Corporation “NTC” (Lincoln, NE) and Aldevron (Fargo, ND) today announced a joint effort to manufacture the world’s first plasmid DNA-based genetic cosmetic for Gene Facelift. (Winston-Salem, North Carolina). Read More...
Aldevron manufacturing certified by CDC for select agents
03/23/11 11:15
Aldevron announced today that they have received Center for Disease Control (CDC) certification for manufacturing select agents. Read More...
Aldevron and Inserm co-develop a novel antibody-based approach for prevention and treatment of chronic hepatitis C
09/10/10 13:53
Aldevron’s German division and Inserm (Strasbourg, France), have developed an antibody that blocks the Hepatitis C virus from entering and infecting liver cells. Read More...
Aldevron licenses HyperGRO™ DNA manufacturing technology from Nature Technology Corporation
07/27/10 11:31
Aldevron has licensed the HyperGRO™ DNA production processes from Nature Technology Corporation (NTC) for use in Aldevron’s clinical manufacturing programs. Read More...
Aldevron Announces Expansion in Madison, WI
10/23/09 11:17
Aldevron, a biotechnology company based in Fargo, ND, has today announced that the company is expanding into Madison, WI. The new division will produce and sell contract research and manufacturing services marketed under the Aldevron brand. Read More...